← Open Payments lookup

ERIN PETRUSIC: Open Payments

NPI 1124432497 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$146,646 in 234 payments from 12 companies in 2025. Trend: 2023 $121,438 · 2024 $88,095 · 2025 $146,646

Speaker / faculty: $116,261Consulting: $14,300Travel & lodging: $10,852Food & beverage: $5,217Education: $17
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.153$139,575
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$4,418
E.R. Squibb & Sons, L.L.C.16$1,260
ABBVIE INC.10$284
Vanda Pharmaceuticals Inc.9$264
Alkermes, Inc.6$260
Teva Pharmaceuticals USA, Inc.6$207
Lundbeck LLC7$142
Axsome Therapeutics, Inc.3$84
Noven Therapeutics, LLC4$64

Products named: INGREZZA, CAPLYTA, COBENFY, VRAYLAR, FANAPT, AUSTEDO XR, ARISTADA, LYBALVI.

Industry payments across IL — which companies pay providers there.